Recruiting Q702 for the Treatment of Patients With Hematologic Malignancies NCT06712810 Conditions Blastic Plasmacytoid Dendritic Cell Neoplasm, Blood Protein Disorders, Bone Marrow Diseases, +87 more Locations Mayo Clinic in Arizona — Scottsdale, Arizona, United States Mayo Clinic in Rochester — Rochester, Minnesota, United States View Trial Details
Not Yet Recruiting ABBV-383 for the Treatment of Relapsed Refractory Waldenström Macroglobulinemia NCT07420959 Conditions Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more Locations Mayo Clinic in Rochester — Rochester, Minnesota, United States View Trial Details
Completed Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas NCT02332980 Conditions Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +48 more Locations Mayo Clinic in Arizona — Scottsdale, Arizona, United States Mayo Clinic in Rochester — Rochester, Minnesota, United States View Trial Details
